Use the search parameters below to filter talks:

Calendar
Calendar

2010 - TTS International Congress (Vancouver)

Epidemiology and Clinical Outcomes
16 August 2010  /  12:14 - 13:14

100.4

The long-term outcomes of kidney transplants with multiple renal arteries

Presenter: Jeong kye Hwang, Seoul, Korea
Authors: Moon I., Hwang J., Kim J., Park S., Yang C., Kim S., Koh Y.

100.4 - The long-term outcomes of kidney transplants with multiple renal arteries

Presenter: Jeong kye Hwang, Seoul, Korea
Authors: Moon I., Hwang J., Kim J., Park S., Yang C., Kim S., Koh Y.

100.7

The Evolving Outcomes of Kidney Transplant Recipients Over 70 Years of Age

Presenter: Islam Ghoneim, Cleveland, United States
Authors: Ghoneim I., Tiong H., Schold J., Srinivas T., Modlin C., Goldfarb D., Flechner S.

100.7 - The Evolving Outcomes of Kidney Transplant Recipients Over 70 Years of Age

Presenter: Islam Ghoneim, Cleveland, United States
Authors: Ghoneim I., Tiong H., Schold J., Srinivas T., Modlin C., Goldfarb D., Flechner S.

100.9

African American Race as a Risk Factor in Outcomes After Second and Third Kidney Transplantation

Presenter: Jennifer McGee, New Orleans, United States
Authors: McGee J., Chou L., Harbin A., Hsueh Y., Yau C., Slakey D.

100.9 - African American Race as a Risk Factor in Outcomes After Second and Third Kidney Transplantation

Presenter: Jennifer McGee, New Orleans, United States
Authors: McGee J., Chou L., Harbin A., Hsueh Y., Yau C., Slakey D.

100.11

Statistical Assessment of a Rate of Post-Transplant Lymphoproliferative Disorder among EBV-positive Kidney Recipients

Presenter: LaRee Tracy, Silver Spring, United States
Authors: Tracy L., Tracy L., Archdeacon P., Messersmith E.

100.11 - Statistical Assessment of a Rate of Post-Transplant Lymphoproliferative Disorder among EBV-positive Kidney Recipients

Presenter: LaRee Tracy, Silver Spring, United States
Authors: Tracy L., Tracy L., Archdeacon P., Messersmith E.

Living Liver Donors and Techniques
16 August 2010  /  12:14 - 13:14

101.6

Contemporaneous portal and arterial reperfusion versus portal reperfusion first during liver transplantation: a prospective randomized study

Presenter: Umberto Baccarani, Udine, Italy
Authors: Baccarani U., Rossetto A., Lorenzin D., Musolino C., Comuzzi C., Bresadola V., Adani G.

101.6 - Contemporaneous portal and arterial reperfusion versus portal reperfusion first during liver transplantation: a prospective randomized study

Presenter: Umberto Baccarani, Udine, Italy
Authors: Baccarani U., Rossetto A., Lorenzin D., Musolino C., Comuzzi C., Bresadola V., Adani G.

101.11

Importance of Liver Biopsy in the Selection of Living-Donors for Liver Transplantation

Presenter: Sinasi Sevmis, Ankara, Turkey
Authors: Sevmis S., Aktas S., Karakayali H., Demirhan B., Selcuk H., Haberal M.

101.11 - Importance of Liver Biopsy in the Selection of Living-Donors for Liver Transplantation

Presenter: Sinasi Sevmis, Ankara, Turkey
Authors: Sevmis S., Aktas S., Karakayali H., Demirhan B., Selcuk H., Haberal M.

101.9

The Pattern of Graft Volume Change After Living Donor Liver Transplantation

Presenter: Man Ki Ju, ,
Authors: Ju M., Huh K., Joo D., Choi J., Kim M., Kim S.

101.9 - The Pattern of Graft Volume Change After Living Donor Liver Transplantation

Presenter: Man Ki Ju, ,
Authors: Ju M., Huh K., Joo D., Choi J., Kim M., Kim S.

101.10

Liver transplantation in the presence of diffuse portal vein thrombosis: A 10 year experience with cavoportal hemitransposition.

Presenter: John Söfteland, Göteborg, Sweden
Authors: Söfteland J., Kvarnström N., Friman S., Olausson M.

101.10 - Liver transplantation in the presence of diffuse portal vein thrombosis: A 10 year experience with cavoportal hemitransposition.

Presenter: John Söfteland, Göteborg, Sweden
Authors: Söfteland J., Kvarnström N., Friman S., Olausson M.

101.7

Long term outcome of ex situ right lobe split grafts in Liver Transplantation

Presenter: Roberto Valente, London,
Authors: Valente R., Dar F., Cherian T., Jassem W., O'Grady j., Agarwal K., Aluvihare V., Heneghan M., Suddle A., Vilca Melendez H., Prachalias A., Srinivasan P., Rela M., Heaton N.

101.7 - Long term outcome of ex situ right lobe split grafts in Liver Transplantation

Presenter: Roberto Valente, London,
Authors: Valente R., Dar F., Cherian T., Jassem W., O'Grady j., Agarwal K., Aluvihare V., Heneghan M., Suddle A., Vilca Melendez H., Prachalias A., Srinivasan P., Rela M., Heaton N.

101.8

Prevention of ischemic type biliary lesions by arterial first reperfusion in orthotopic liver transplantation

Presenter: Frank Ulrich, Frankfurt/Main, Germany
Authors: Ulrich F., Kohler S., Hofmann W., Sarrazin C., Zeuzem S., Bechstein W., Mönch C.

101.8 - Prevention of ischemic type biliary lesions by arterial first reperfusion in orthotopic liver transplantation

Presenter: Frank Ulrich, Frankfurt/Main, Germany
Authors: Ulrich F., Kohler S., Hofmann W., Sarrazin C., Zeuzem S., Bechstein W., Mönch C.

Laboratory Immunology and Kidney Transplantation
16 August 2010  /  12:14 - 13:14

102.2

Predicting Outcomes in Kidney Transplantation: A Comparison of Three Semi-Quantitative Proteinuria Tests

Presenter: Bryce Kiberd, Halifax, Canada
Authors: Kiberd B.

102.2 - Predicting Outcomes in Kidney Transplantation: A Comparison of Three Semi-Quantitative Proteinuria Tests

Presenter: Bryce Kiberd, Halifax, Canada
Authors: Kiberd B.

102.1

Creatinine and Cystatin C-based Equations for the Estimation of Glomerular Filtration Rate in Kidney Transplantation: Correlation with Histopathology

Presenter: Ender Hur, Izmir, Turkey
Authors: Hur E., Sen C., Nart A., Sen S., Akgun A., Tasli F., Yilmaz M., Uslu A., Toz H.

102.1 - Creatinine and Cystatin C-based Equations for the Estimation of Glomerular Filtration Rate in Kidney Transplantation: Correlation with Histopathology

Presenter: Ender Hur, Izmir, Turkey
Authors: Hur E., Sen C., Nart A., Sen S., Akgun A., Tasli F., Yilmaz M., Uslu A., Toz H.

102.4

Expression of E-cadherin, HSP(Heat Shock Protein)47, TGF-β1 and C4d in Chronic Allograft Nephropathy

Presenter: Samuel Lee, Seoul, Korea
Authors: Lee S., Chung Y., Park J., Kim D., Park S., Kim J., Hyun S., Nam E.

102.4 - Expression of E-cadherin, HSP(Heat Shock Protein)47, TGF-β1 and C4d in Chronic Allograft Nephropathy

Presenter: Samuel Lee, Seoul, Korea
Authors: Lee S., Chung Y., Park J., Kim D., Park S., Kim J., Hyun S., Nam E.

102.3

Glomerulitis during Acute Cellular Rejection May be a Surrogate Marker of Vasculitis in Renal Allografts (Better Index for Diagnosis of Vasculitis)

Presenter: Ping Zhang, Royal Oak, United States
Authors: Zhang P., Farinola M., Samarapungavan D., Rooney M., Hicks S., Cohn S., Reddy G., Rocher L., Dumler F., Parasuraman R.

102.3 - Glomerulitis during Acute Cellular Rejection May be a Surrogate Marker of Vasculitis in Renal Allografts (Better Index for Diagnosis of Vasculitis)

Presenter: Ping Zhang, Royal Oak, United States
Authors: Zhang P., Farinola M., Samarapungavan D., Rooney M., Hicks S., Cohn S., Reddy G., Rocher L., Dumler F., Parasuraman R.

102.5

Donor-Specific HLA Antibodies Detected by Single Antigen Beads in Renal Transplant Patients: Impact on Clinical Outcome

Presenter: Juha Peräsaari, Helsinki, Finland
Authors: Peräsaari J., Kyllönen L., Salmela K., Merenmies J.

102.5 - Donor-Specific HLA Antibodies Detected by Single Antigen Beads in Renal Transplant Patients: Impact on Clinical Outcome

Presenter: Juha Peräsaari, Helsinki, Finland
Authors: Peräsaari J., Kyllönen L., Salmela K., Merenmies J.

102.7

Biochemical markers of bone turnover and genotyping of polymorphisms and bone densitometry as standard test in the study of bone disease in renal transplant patients.

Presenter: LUISA JIMENO-GARCIA, MURCIA, Spain
Authors: JIMENO-GARCIA L., GONZALEZ-SORIANO M., GIL-DEL CASTILLO L., NOGUERA-VELASCO J., TOVAR-ZAPATA I., MARTINEZ-HERNANDEZ P.

102.7 - Biochemical markers of bone turnover and genotyping of polymorphisms and bone densitometry as standard test in the study of bone disease in renal transplant patients.

Presenter: LUISA JIMENO-GARCIA, MURCIA, Spain
Authors: JIMENO-GARCIA L., GONZALEZ-SORIANO M., GIL-DEL CASTILLO L., NOGUERA-VELASCO J., TOVAR-ZAPATA I., MARTINEZ-HERNANDEZ P.

102.8

Bortezomib Therapy for Antibody-Mediated Rejection: Effect on graft function and HLA Donor-Specific Antibody level.

Presenter: Luis Morales-Buenrostro, Mexico City, Mexico
Authors: Morales-Buenrostro L., Leyva S., Marino-Vazquez L., Vega-Vega O., Cantu G.

102.8 - Bortezomib Therapy for Antibody-Mediated Rejection: Effect on graft function and HLA Donor-Specific Antibody level.

Presenter: Luis Morales-Buenrostro, Mexico City, Mexico
Authors: Morales-Buenrostro L., Leyva S., Marino-Vazquez L., Vega-Vega O., Cantu G.

102.9

A Graded Desensitization Treatment Protocol for Management of Living Donor Recipients with Donor Specific Antibody

Presenter: Richard Knight, Houston, United States
Authors: Patel S., Knight R., Achkar K., Land G., Dilioglou S., Hamilton J., Barretto P., Gaber A.

102.9 - A Graded Desensitization Treatment Protocol for Management of Living Donor Recipients with Donor Specific Antibody

Presenter: Richard Knight, Houston, United States
Authors: Patel S., Knight R., Achkar K., Land G., Dilioglou S., Hamilton J., Barretto P., Gaber A.

102.6

A Banff cv2 lesion in a pre-implantation biopsy is the best predictor of delayed graft function following renal transplantation.

Presenter: Benjamin Philosophe, Baltimore, United States
Authors: Munivenkatappa R., Malat G., Soundararajan S., Ranganna K., Drachenberg C., Papadimtriou J., Fayek S., Barth R., Cooper M., David K., Schweitzer E., Bartlett S., Kumar M., Philosophe B.

102.6 - A Banff cv2 lesion in a pre-implantation biopsy is the best predictor of delayed graft function following renal transplantation.

Presenter: Benjamin Philosophe, Baltimore, United States
Authors: Munivenkatappa R., Malat G., Soundararajan S., Ranganna K., Drachenberg C., Papadimtriou J., Fayek S., Barth R., Cooper M., David K., Schweitzer E., Bartlett S., Kumar M., Philosophe B.

102.10

C4d binding correlated with strong HLA antibodies can cause graft failure

Presenter: Kazuo Mizutani, Nagoya, Japan
Authors: Mizutani K., Gotoh M., Terasaki P.

102.10 - C4d binding correlated with strong HLA antibodies can cause graft failure

Presenter: Kazuo Mizutani, Nagoya, Japan
Authors: Mizutani K., Gotoh M., Terasaki P.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • onelambda
  • roche
  • sanofi